Stevard, LLC Moderna, Inc. Transaction History

Stevard, LLC

$115 Million
Q2 2024

A detailed history of Stevard, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Stevard, LLC holds 7,350 shares of MRNA stock, worth $391,681. This represents 0.76% of its overall portfolio holdings.

Number of Shares

7,350

Previous 7,851 6.38%

Holding current value

$391,681

Previous $836,000 4.31%

% of portfolio

0.76%

Previous 0.76%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$101.21 - $166.61 $50,706 - $83,471	-501 Reduced 6.38%	7,350 $872,000
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $6,186 - $9,294	-89 Reduced 1.12%	7,851 $780,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $2,506 - $3,291	-26 Reduced 0.33%	7,940 $820,000
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $26,307 - $35,637	-222 Reduced 2.71%	7,966 $967,000
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $7,438 - $12,233	-63 Reduced 0.76%	8,188 $968,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $68,414 - $127,162	-541 Reduced 6.15%	8,251 $1.42 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $180,881 - $295,176	-801 Reduced 8.35%	8,792 $2.23 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $490,177 - $1.07 Million	2,209 Added 29.92%	9,593 $3.69 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $68,072 - $123,129	524 Added 7.64%	7,384 $1.74 Million
Q1 2021 Aug 13, 2021	SELL	$109.18 - $185.98 $53,825 - $91,688	-493 Reduced 6.7%	6,860 $898,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $454,000 - $1.17 Million	-6,906 Reduced 48.43%	7,353 $768,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $141,284 - $246,609	2,600 Added 22.3%	14,259 $1.01 Million
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $345,922 - $932,720	11,659 New	11,659 $749,000

Others Institutions Holding MRNA

# of Institutions

1,030

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $20.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevard, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stevard, LLC with notifications on news.

Account